Private pharmacists are reviewing the new Medical Products Act, they said on Wednesday, raising concerns about how its provisions could affect the domestic drug supply and regulatory environment.

The bill, which passed in the House of Assembly on Tuesday after already being cleared by Senate lawmakers, aims to tighten control over the quality and supply of medicines to guard against counterfeit drugs and reduce reliance on external sources.

President of the Pharmaceutical Society of Barbados, Marlon Ward Rogers, said on Wednesday his organisation was now carefully examining the provisions of the measure as they would affect the industry.